Clinical trial
PREVALENCE STUDY OF PNH CLONES IN PATIENTS WITH NEOPLASIES MYELOPROLIFERATIVE PHILADELPHIA-NEGATIVE
NCT06159816 is registered in ClinicalTrials.gov with AUSL Romagna Rimini as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PREVALENCE STUDY OF PNH CLONES IN PATIENTS WITH NEOPLASIES MYELOPROLIFERATIVE PHILADELPHIA-NEGATIVE
- Lead sponsor
- AUSL Romagna Rimini
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 1, 2017
- Completion date
- January 1, 2022
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myeloproliferative neoplasm